In a parallel SEC enforcement action, Bio-Rad will pay $40.7 million in disgorgement (paying back the profits it earned illegally) and prejudgment interest. Because Bio-Rad was cooperative, the SEC resolved its claims through an administrative order, rather then going through the more expensive and more time-consuming court route. The SEC said that Bio-Rad violated the Anti-bribery, Internal Controls, and Books and Records Provisions of the FCPA. The SEC alleged that Bio-Rad "…lacked sufficient internal controls to prevent or detect approximately $7.5 million in bribes that were paid during a five-year period and improperly recorded in books and records as legitimate expenses like commissions, advertising, and training fees." Bio-Rad made $35 million in profits through those bribes, according to the SEC.